Literature DB >> 17485643

Focality of upper and lower motor neuron degeneration at the clinical onset of ALS.

John Ravits1, Piper Paul, Cathy Jorg.   

Abstract

OBJECTIVE: To localize and analyze the anatomic distribution of upper motor neuron (UMN) and lower motor neuron (LMN) loss in patients with ALS early in their disease when motor manifestations were still relatively focal using clinical examination signs.
METHODS: We reviewed records of 100 patients with ALS who were evaluated when the diagnosis was first established or suspected. From the patient history, we ascertained the body region of first symptoms and the time course. From the physical examination, we separately graded severity of UMN and LMN signs in each body region, indexed these to the body region of first symptoms, and sorted and analyzed the data.
RESULTS: Motor manifestations began in one body region in 98% of patients. UMN and LMN signs were both maximal in these same body regions, but they were independent of each other in severity and their outward distribution, which conformed to neuronal anatomy. The outward distribution of both UMN and LMN signs seemed more directed to caudal body regions than to rostral ones.
CONCLUSIONS: Motor neuron degeneration in ALS is a focal process at both upper and lower motor neuron levels of the motor system. At each level, it begins corresponding to the same peripheral body region and then advances contiguously and separately to summate over time.

Entities:  

Mesh:

Year:  2007        PMID: 17485643     DOI: 10.1212/01.wnl.0000260965.20021.47

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  102 in total

Review 1.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

2.  Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).

Authors:  Kai F Loewenbrück; Julia Liesenberg; Markus Dittrich; Jochen Schäfer; Beate Patzner; Beate Trausch; Jochen Machetanz; Andreas Hermann; Alexander Storch
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

3.  Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.

Authors:  Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  J Neurol       Date:  2013-08-31       Impact factor: 4.849

Review 4.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

Review 5.  Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

Authors:  Kevin Talbot
Journal:  J Anat       Date:  2013-09-08       Impact factor: 2.610

Review 6.  Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.

Authors:  Heiko Braak; Johannes Brettschneider; Albert C Ludolph; Virginia M Lee; John Q Trojanowski; Kelly Del Tredici
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

7.  Pattern of spread and prognosis in lower limb-onset ALS.

Authors:  Martin R Turner; Alice Brockington; Jakub Scaber; Hannah Hollinger; Rachael Marsden; Pamela J Shaw; Kevin Talbot
Journal:  Amyotroph Lateral Scler       Date:  2010-08

8.  Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis.

Authors:  Esther Verstraete; Jan H Veldink; Leonard H van den Berg; Martijn P van den Heuvel
Journal:  Hum Brain Mapp       Date:  2013-03-01       Impact factor: 5.038

9.  Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.

Authors:  Jacob I Ayers; Susan E Fromholt; Veronica M O'Neal; Jeffrey H Diamond; David R Borchelt
Journal:  Acta Neuropathol       Date:  2015-12-09       Impact factor: 17.088

Review 10.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.